Khiron

NEWS PROVIDED BY

Khiron Life Sciences Corp. 

Sep 25, 2019, 00:01 ET


TORONTOSept. 25, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company has received approval from INVIMA, Colombia's health agency, to sell 3 additional Kuida® CBD skin care products. This expands on the 7 products currently available at retail and online in Colombia, with first sales of the newly approved product expected in Q4.



Comments